Overview

Gender

male

Geoffrey Crouse joined CBR as CEO in September 2012. He previously served as Chief Operating Officer at Immucor, a publicly traded global in vitro diagnostics company that was sold to TPG in 2011. Prior to Immucor, he served as vice president of the life sciences business at Millipore Corporation, a NYSE-traded provider of technologies, tools and services for the global life science industry. In this role, he led the Life Science Strategic Business Unit, a global laboratory consumables and reagents business. Prior to joining Millipore, he worked at Roche, a leader in the pharmaceuticals and diagnostics industries, where he led market development and government affairs for the diagnostics division based in Basel, Switzerland. Geoffrey earned a B.A. from Boston College and an M.B.A. and Masters of Public Health from the University of California at Berkeley.